middle.news
Clarity Pharmaceuticals Builds Toward US Prostate Imaging Launch
3:45pm on Wednesday 30th of September, 2026 AEST
•
Biotechnology and Pharmaceuticals
Read Story
Clarity Pharmaceuticals Builds Toward US Prostate Imaging Launch
3:45pm on Wednesday 30th of September, 2026 AEST
Key Points
AMPLIFY closed recruitment with 232 participants; CLARIFY is nearing completion
Co-PSMA detected 2.63 times more lesions than 68Ga-PSMA-11 in a 50-patient study
Seven participants achieved complete response or undetectable disease across the 67Cu-SAR-bisPSMA program
AUD178.3 million in liquid assets after a AUD203 million institutional placement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clarity Pharmaceuticals (ASX:CU6)
OPEN ARTICLE